TUBERCULOSIS RESOURCES

​​​​​​​TB VACCINES​​​​

Bacterial vaccines in clinical and preclinical development 2021: An overview and analysis

​​Can a Recombinant BCG Vaccine Better Protect HIV-Positive Children?

​ICMR to begin study to evaluate BCG booster dose for kids, adolescents

Does BCG vaccination protect against infection with M. tuberculosis?

​Inhaled vaccine for COVID-19: The pandemic accelerated decades of research leading to jab-free vaccine now in human testing

​Delayed Adaptive Immune Response to Tuberculosis Points to Vaccination Strategies

Can we improve on a once-in-a-century TB vaccine?

Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro

​Preparing For TB, Polio, Measles, and COVID-19 Outbreaks

​WHO calls for urgent BCG alternative

​​Good and bad news about new TB vaccines

The Scientist - Infographic: TB Vaccines in the Pipeline Take Varied Approaches

​

Stop TB Partnership - STATEMENT ON BCG VACCINATION AND COVID-19 New Tools Working Groups

​TB 101

Understanding the Connection Between HIV and Tuberculosis
​

Global TB Caucus: TB video series

How to Protect Ourselves from TB

​Common Budgetary Terms Explained

NCHHSTP Metrics Dashboard: TB Elimination

Global Health Impact Index

How Tuberculosis Spreads (video)​

The Scientist - Tuberculosis: The Forgotten Pandemic

TAG - 2021 TB Pipeline Report

WHO - Tuberculosis​

CDC - Tuberculosis ​

Where we unite to #EndTB!

Find TB and COVID resources on our TB & COVID page here!​

​​​​​​​​​TB REPORTS​​

Health systems in crisis: The Global Fund's impact in Ukraine

​DIGITAL TB SURVEILLANCE SYSTEM ASSESSMENT REPORT

Consolidated report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services

Friends of the Global Fight Investment Case

​The impact of COVID-19 on TB: a review of the data

TB Elimination Alliance Impact Report 2020-2021

TAG - 2021 TB Pipeline Report

​Stop TB Partnership - EXECUTIVE BRIEF: Key Findings and Calls to Action

Stop TB Partnership - Civil Society Report on TB and COVID

​DevPolicy Blog - Progress towards ending TB at risk

​FACT SHEET: The Biden Administration’s Commitment to Global Health

​

​​​​​​​​​​​​​​​​​TB GUIDES

Una Guia Para Activistas Sobre Herramientas De Diagnostico De La Tuberculosis [An Activist’s Guide to Tuberculosis Diagnostic Tools]

Preventing Tuberculosis in Your Clinical Setting: A Practical Guidebook

Management of Drug-Resistant Tuberculosis in Pregnant and Peripartum People: A FIELD GUIDE

Guidance for national strategic planning for tuberculosis

Tuberculosis: Clinical Policies and Program Manual

Preventing TB in Your Clinical Setting- A Practical Guidebook

NTCA Provider Guidance: A 4-Month Regimen to Treat Pulmonary Tuberculosis: Isoniazid, Rifampin, Moxifloxacin, and Pyrazinamide (HPMZ).

WHO announces updates on its guidance on tuberculosis care and support

WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support

WHO consolidated guidelines on tuberculosis: module 4: treatment: tuberculosis care and support

Cultural Quick Reference Guide: Ukraine

Uniting for Ukraine: Information for TB Programs

Clinical standards for drug-susceptible pulmonary TB

​TB Language Guide 2.0 launched at Stop TB Partnership Board meeting

Provisional CDC Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease

Severe COVID-19: A TB Risk Factor

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment

Human rights, informed consent, and high ethical standards as a basis for people-centered TB care

Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide

​Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis

Practical manual of processing stool samples for diagnosis of childhood TB

Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians

WHO issues Information Note on ensuring continuity of essential TB services for people with or at risk of the disease in Ukraine and refugee-hosting countries

Virtual Meeting of the Global Multisectoral and Multi-stakeholder Platform to end TB

How to Treat Drug-Resistant Tuberculosis

​Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing

Tuberculosis in the time of COVID-19

Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing

​Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine

Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex

Managing Drug Interactions in HIV and TB Coinfection Is Complex

Information sheet: Management of tuberculosis in children and adolescents

WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents

WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents

An Activist’s Guide to Rifapentine for the Treatment of TB Infection

Clinical standards for the diagnosis, treatment and prevention of TB infection

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022

TB Provider Toolkit

Clinical standards for the diagnosis, treatment and prevention of TB infection

​Building Resilience: Keeping Mentally Healthy to Keep Moving Forward

New American Academy of Pediatrics statement on testing for and treating TB infection in children: Tuberculosis Infection in Children and Adolescents: Testing and Treatment

​The Mantoux Tuberculin Skin Test Wall Chart